Prosecution Insights
Last updated: May 29, 2026

Examiner: HARTLEY, MICHAEL G

Tech Center 1600 • Art Units: 1600 1611 1618

This examiner grants 34% of resolved cases

Performance Statistics

34.3%
Allow Rate
-25.7% vs TC avg
75
Total Applications
+79.3%
Interview Lift
1571
Avg Prosecution Days
Based on 67 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
7.6%
§102 Novelty
67.3%
§103 Obviousness
12.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17365733 DESIGN AND DEVELOPMENT OF NEUROKININ-1 RECEPTOR-BINDING AGENT DELIVERY CONJUGATES Final Rejection Purdue Research Foundation
17053691 MAGNETIC LIPOSOMES AND RELATED TREATMENT AND IMAGING METHODS Non-Final OA UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED
16964733 CONJUGATABLE DESMOGLEIN 2 (DSG2) BINDING PROTEINS AND USES THEREFOR Final Rejection HDT BIO CORP.
17633437 COSMETIC SKIN HYDRATION COMPLEX, USE OF THE COSMETIC COMPLEX, COSMETIC COMPOSITION AND METHOD FOR SKIN HYDRATION Final Rejection Natura Cosméticos S.A.
18109031 Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications Final Rejection InFlectis BioScience
17484727 Enhanced in Vivo Targeting of Site-Specific Drugs Non-Final OA Advanced Accelerator Applications USA, Inc.
17264944 POLYPEPTIDE DELIVERY COMPOSITION Non-Final OA LEMONEX INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month